市場調査レポート

商品コード

1245405

セルライト治療の世界市場規模予測（2023年～2032年）

Global Cellulite Treatment Market Forecast 2023-2032

出版日: 2023年03月24日 | 発行: Inkwood Research

| ページ情報: 英文 232 Pages | 納期: 2～3営業日

価格

Unprintable PDF (Single User License)

USD 2,900 455,706円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

PDF (Corporate License)

USD 4,500 707,130円

レポートPDFを同一企業内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のセルライト治療の市場規模は、2023年から2032年の予測期間中に9.44%のCAGRで成長すると予測されています。同市場を牽引する要因には、審美・美容施術の需要の増加、肥満の症例の増加、医療ツーリズム業界の急成長などが挙げられます。

当レポートでは、セルライト治療の世界市場を調査し、市場の概要と動向、市場の促進要因・抑制要因、セグメント別・地域別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

親市場分析
主要な技術動向
ポーターのファイブフォース分析
- 買い手の力
- 供給企業の力
- 代替
- 新規参入者
- 業界の競争
成長見通しのマッピング
市場成熟度分析
市場集中分析
バリューチェーン分析
- 研究開発
- 製品開発
- マーケティングと流通
- 販売後のモニタリング
主要な購入基準
- 料金
- ブランドの評判
- 使いやすさ

第5章施術別の市場

非侵襲的
低侵襲
局所

第6章タイプ別の市場

ソフトセルライト
ハードセルライト
浮腫性セルライト

第7章エンドユーザー別の市場

病院
クリニックと美容センター
その他のエンドユーザー

第8章地域分析

北米
- 市場規模・推計
- 促進要因
- 課題
- 規制の枠組み
- 主要企業
- 国別分析
欧州
- 市場規模・推計
- 促進要因
- 課題
- 規制の枠組み
- 主要企業
- 国別分析
アジア太平洋地域
- 市場規模・推計
- 促進要因
- 課題
- 規制の枠組み
- 主要企業
- 国別分析
世界のその他の地域
- 市場規模・推計
- 促進要因
- 課題
- 規制の枠組み
- 主要企業
- 地域分析

第9章競合情勢

主要な戦略的展開
- 買収
- 製品の発売と開発
- パートナーシップと契約
- 拡張と売却
企業プロファイル
- ABBVIE INC
- ALMA LASERS
- BAUSCH HEALTH COMPANIES INC.
- CANDELA CORPORATION
- CUTERA INC
- CYNOSURE LLC
- ENDO INTERNATIONAL PLC
- GALDERMA SA
- INCELER MEDIKAL CO LTD
- JOHNSON & JOHNSON
- MERZ PHARMA GMBH & CO KGAA
- NUBWAY CO LTD
- SIENTRA INC
- SINCLAIR PHARMA
- ZIMMER MEDIZINSYSTEME

図表

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - CELLULITE TREATMENT
TABLE 2: GLOBAL CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: GLOBAL CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: GLOBAL NON-INVASIVE CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: GLOBAL NON-INVASIVE CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: GLOBAL MINIMALLY INVASIVE CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: GLOBAL MINIMALLY INVASIVE CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: GLOBAL TOPICAL CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: GLOBAL TOPICAL CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: GLOBAL CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: GLOBAL CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 12: GLOBAL SOFT CELLULITE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: GLOBAL SOFT CELLULITE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 14: GLOBAL HARD CELLULITE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: GLOBAL HARD CELLULITE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 16: GLOBAL EDEMATOUS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: GLOBAL EDEMATOUS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 18: GLOBAL CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 19: GLOBAL CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 20: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 21: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 22: GLOBAL CLINICS AND BEAUTY CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 23: GLOBAL CLINICS AND BEAUTY CENTERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 24: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 25: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 26: GLOBAL CELLULITE TREATMENT MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 27: GLOBAL CELLULITE TREATMENT MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 28: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 29: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 30: NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 31: LEADING PLAYERS OPERATING IN NORTH AMERICA CELLULITE TREATMENT MARKET
TABLE 32: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 33: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 34: EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 35: LEADING PLAYERS OPERATING IN EUROPE CELLULITE TREATMENT MARKET
TABLE 36: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 37: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 38: ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 39: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
TABLE 40: REST OF WORLD CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 41: REST OF WORLD CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 42: REST OF WORLD CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 43: LEADING PLAYERS OPERATING IN REST OF WORLD CELLULITE TREATMENT MARKET
TABLE 44: LIST OF ACQUISITIONS
TABLE 45: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 46: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 47: LIST OF EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY TECHNOLOGY TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: GLOBAL CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY PROCEDURE, IN 2022
FIGURE 9: GLOBAL CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 10: GLOBAL CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 11: GLOBAL CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2032 (IN $ MILLION)
FIGURE 12: GLOBAL CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
FIGURE 13: GLOBAL CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 14: GLOBAL CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 15: GLOBAL CELLULITE TREATMENT MARKET, BY EDEMATOUS CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 16: GLOBAL CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 17: GLOBAL CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)
FIGURE 18: GLOBAL CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2032 (IN $ MILLION)
FIGURE 19: GLOBAL CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)
FIGURE 20: NORTH AMERICA CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 21: UNITED STATES CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: CANADA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: EUROPE CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 24: UNITED KINGDOM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: GERMANY CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 26: FRANCE CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 27: ITALY CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 28: BELGIUM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 29: POLAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 30: REST OF EUROPE CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)
FIGURE 32: CHINA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 33: JAPAN CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 34: INDIA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 35: SOUTH KOREA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 36: THAILAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 37: INDONESIA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 38: VIETNAM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 39: AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 40: REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 41: REST OF WORLD CELLULITE TREATMENT MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)
FIGURE 42: LATIN AMERICA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 43: MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 44: ABBVIE INC COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 45: ABBVIE INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 46: ABBVIE INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 47: BAUSCH HEALTH COMPANIES INC COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 48: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 49: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 50: CUTERA INC COMPANY PROFIT 2017 - 2021 ($ MILLION)
FIGURE 51: CUTERA INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 52: CUTERA INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 53: ENDO INTERNATIONAL PLC COMPANY PROFIT 2018 - 2021 ($ MILLION)
FIGURE 54: ENDO INTERNATIONAL PLC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 55: ENDO INTERNATIONAL PLC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 56: JOHNSON & JOHNSON COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 57: JOHNSON & JOHNSON COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 58: JOHNSON & JOHNSON COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 59: JOHNSON & JOHNSON COMPANY REVENUE 2017 - 2021 ($ BILLION)
FIGURE 60: SIENTRA INC COMPANY PROFIT 2017 - 2021 ($ MILLION)

Product Code: 50829

KEY FINDINGS

The global cellulite treatment market is anticipated to register a CAGR of 9.44% during the forecast period 2023-2032. Some of the key drivers facilitating the market's growth include the increasing demand for aesthetic and cosmetic procedures, rising cases of obesity, as well as the rapidly booming medical tourism industry.

MARKET INSIGHTS

Cellulite is characterized as fat collections that push against the connective tissue beneath the skin. It appears on the stomach, buttocks, and thighs. Cellulite may be caused due to accumulated toxins, poor diet, genetics, pregnancy, weight gain, and inactivity.

Obesity is one of the leading health concerns globally. Obesity leads to cellulite by virtue of heightening the volume of fat trapped within irregular-sized fat lobules. According to the Centers for Disease Control and Prevention (CDC), obesity prevalence in the United States was more than 41% in 2017. Furthermore, according to the World Health Organization (WHO), approximately 39 million children under the age of 5 were obese or overweight in the year 2020. People with obesity are more vulnerable to health issues like cardiac disorders, diabetes, high blood pressure, strokes, and other conditions. Such health problems encourage individuals to undergo treatment for obesity, thereby facilitating the global cellulite treatment market growth.

REGIONAL INSIGHTS

The global cellulite treatment market growth analysis covers a detailed assessment of North America, Europe, Asia-Pacific, and Rest of World. The Asia-Pacific is set to grow with the highest CAGR during the forecast period. The regional market's growth is primarily ascribed to the presence of skilled professionals and high-quality healthcare facilities, in addition to the lower cost of treatments and premium healthcare services.

COMPETITIVE INSIGHTS

The degree of industrial rivalry within the global cellulite treatment market is projected to be high during the forecast period. Some of the key companies operating in the market are: Johnson & Johnson, AbbVie Inc, Bausch Health Companies Inc, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
- 2.5.1. RISING BEAUTY CONSCIOUSNESS
- 2.5.2. GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES
- 2.5.3. TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH
- 2.5.4. RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
- 3.1.2. RISING CASES OF OBESITY
- 3.1.3. RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY
3.2. KEY RESTRAINTS
- 3.2.1. HIGH COST OF ADVANCED CELLULITE TREATMENT
- 3.2.2. SIDE EFFECTS POST-TREATMENT
- 3.2.3. LACK OF AWARENESS

4. KEY ANALYTICS

4.1. PARENT MARKET ANALYSIS
4.2. KEY TECHNOLOGY TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
- 4.7.1. RESEARCH AND DEVELOPMENT
- 4.7.2. PRODUCT DEVELOPMENT
- 4.7.3. MARKETING AND DISTRIBUTION
- 4.7.4. POST-SALES MONITORING
4.8. KEY BUYING CRITERIA
- 4.8.1. COST
- 4.8.2. BRAND REPUTATION
- 4.8.3. USABILITY

5. MARKET BY PROCEDURE

5.1. NON-INVASIVE
5.2. MINIMALLY INVASIVE
5.3. TOPICAL

6. MARKET BY TYPE

6.1. SOFT CELLULITE
6.2. HARD CELLULITE
6.3. EDEMATOUS CELLULITE

7. MARKET BY END-USER

7.1. HOSPITALS
7.2. CLINICS AND BEAUTY CENTERS
7.3. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

8.1. NORTH AMERICA
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. NORTH AMERICA CELLULITE TREATMENT MARKET DRIVERS
- 8.1.3. NORTH AMERICA CELLULITE TREATMENT MARKET CHALLENGES
- 8.1.4. NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
- 8.1.5. KEY PLAYERS IN NORTH AMERICA CELLULITE TREATMENT MARKET
- 8.1.6. COUNTRY ANALYSIS
  - 8.1.6.1. UNITED STATES
  - 8.1.6.1.1. UNITED STATES CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.2. CANADA
  - 8.1.6.2.1. CANADA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2. EUROPE
- 8.2.1. MARKET SIZE & ESTIMATES
- 8.2.2. EUROPE CELLULITE TREATMENT MARKET DRIVERS
- 8.2.3. EUROPE CELLULITE TREATMENT MARKET CHALLENGES
- 8.2.4. EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
- 8.2.5. KEY PLAYERS IN EUROPE CELLULITE TREATMENT MARKET
- 8.2.6. COUNTRY ANALYSIS
  - 8.2.6.1. UNITED KINGDOM
  - 8.2.6.1.1. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.2.6.2. GERMANY
  - 8.2.6.2.1. GERMANY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.2.6.3. FRANCE
  - 8.2.6.3.1. FRANCE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.2.6.4. ITALY
  - 8.2.6.4.1. ITALY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.2.6.5. BELGIUM
  - 8.2.6.5.1. BELGIUM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.2.6.6. POLAND
  - 8.2.6.6.1. POLAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.2.6.7. REST OF EUROPE
  - 8.2.6.7.1. REST OF EUROPE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3. ASIA-PACIFIC
- 8.3.1. MARKET SIZE & ESTIMATES
- 8.3.2. ASIA-PACIFIC CELLULITE TREATMENT MARKET DRIVERS
- 8.3.3. ASIA-PACIFIC CELLULITE TREATMENT MARKET CHALLENGES
- 8.3.4. ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
- 8.3.5. KEY PLAYERS IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
- 8.3.6. COUNTRY ANALYSIS
  - 8.3.6.1. CHINA
  - 8.3.6.1.1. CHINA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.3.6.2. JAPAN
  - 8.3.6.2.1. JAPAN CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.3.6.3. INDIA
  - 8.3.6.3.1. INDIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.3.6.4. SOUTH KOREA
  - 8.3.6.4.1. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.3.6.5. THAILAND
  - 8.3.6.5.1. THAILAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.3.6.6. INDONESIA
  - 8.3.6.6.1. INDONESIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.3.6.7. VIETNAM
  - 8.3.6.7.1. VIETNAM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.3.6.8. AUSTRALIA & NEW ZEALAND
  - 8.3.6.8.1. AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.3.6.9. REST OF ASIA-PACIFIC
  - 8.3.6.9.1. REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.4. REST OF WORLD
- 8.4.1. MARKET SIZE & ESTIMATES
- 8.4.2. REST OF WORLD CELLULITE TREATMENT MARKET DRIVERS
- 8.4.3. REST OF WORLD CELLULITE TREATMENT MARKET CHALLENGES
- 8.4.4. REST OF WORLD CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
- 8.4.5. KEY PLAYERS IN REST OF WORLD CELLULITE TREATMENT MARKET
- 8.4.6. REGIONAL ANALYSIS
  - 8.4.6.1. LATIN AMERICA
  - 8.4.6.1.1. LATIN AMERICA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.4.6.2. MIDDLE EAST & AFRICA
  - 8.4.6.2.1. MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. ABBVIE INC
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. FINANCIAL ANALYSIS
  - 9.2.1.3. PRODUCTS / SERVICES LIST
  - 9.2.1.4. STRENGTHS & CHALLENGES
- 9.2.2. ALMA LASERS
  - 9.2.2.1. COMPANY OVERVIEW
  - 9.2.2.2. PRODUCTS / SERVICES LIST
- 9.2.3. BAUSCH HEALTH COMPANIES INC.
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. FINANCIAL ANALYSIS
  - 9.2.3.3. PRODUCTS / SERVICES LIST
  - 9.2.3.4. STRENGTHS & CHALLENGES
- 9.2.4. CANDELA CORPORATION
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCTS / SERVICES LIST
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. CUTERA INC
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. FINANCIAL ANALYSIS
  - 9.2.5.3. PRODUCTS / SERVICES LIST
  - 9.2.5.4. STRENGTHS & CHALLENGES
- 9.2.6. CYNOSURE LLC
  - 9.2.6.1. COMPANY OVERVIEW
  - 9.2.6.2. PRODUCTS / SERVICES LIST
  - 9.2.6.3. STRENGTHS & CHALLENGES
- 9.2.7. ENDO INTERNATIONAL PLC
  - 9.2.7.1. COMPANY OVERVIEW
  - 9.2.7.2. FINANCIAL ANALYSIS
  - 9.2.7.3. PRODUCTS / SERVICES LIST
  - 9.2.7.4. STRENGTHS & CHALLENGES
- 9.2.8. GALDERMA SA
  - 9.2.8.1. COMPANY OVERVIEW
  - 9.2.8.2. PRODUCTS / SERVICES LIST
  - 9.2.8.3. STRENGTHS & CHALLENGES
- 9.2.9. INCELER MEDIKAL CO LTD
  - 9.2.9.1. COMPANY OVERVIEW
  - 9.2.9.2. PRODUCTS / SERVICES LIST
  - 9.2.9.3. STRENGTHS & CHALLENGES
- 9.2.10. JOHNSON & JOHNSON
  - 9.2.10.1. COMPANY OVERVIEW
  - 9.2.10.2. FINANCIAL ANALYSIS
  - 9.2.10.3. PRODUCTS / SERVICES LIST
  - 9.2.10.4. STRENGTHS & CHALLENGES
- 9.2.11. MERZ PHARMA GMBH & CO KGAA
  - 9.2.11.1. COMPANY OVERVIEW
  - 9.2.11.2. PRODUCTS / SERVICES LIST
  - 9.2.11.3. STRENGTHS & CHALLENGES
- 9.2.12. NUBWAY CO LTD
  - 9.2.12.1. COMPANY OVERVIEW
  - 9.2.12.2. PRODUCTS / SERVICES LIST
- 9.2.13. SIENTRA INC
  - 9.2.13.1. COMPANY OVERVIEW
  - 9.2.13.2. FINANCIAL ANALYSIS
  - 9.2.13.3. PRODUCTS / SERVICES LIST
  - 9.2.13.4. STRENGTHS & CHALLENGES
- 9.2.14. SINCLAIR PHARMA
  - 9.2.14.1. COMPANY OVERVIEW
  - 9.2.14.2. PRODUCTS / SERVICES LIST
- 9.2.15. ZIMMER MEDIZINSYSTEME
  - 9.2.15.1. COMPANY OVERVIEW
  - 9.2.15.2. PRODUCTS / SERVICES LIST
  - 9.2.15.3. STRENGTHS & CHALLENGES

セルライト治療の世界市場規模予測（2023年～2032年）

Global Cellulite Treatment Market Forecast 2023-2032

目次

第1章調査範囲と調査手法

第2章エグゼクティブサマリー

第3章市場力学

第4章主要な分析

第5章施術別の市場

第6章タイプ別の市場

第7章エンドユーザー別の市場

第8章地域分析

第9章競合情勢

LIST OF TABLES

LIST OF FIGURES

KEY FINDINGS

MARKET INSIGHTS

REGIONAL INSIGHTS

COMPETITIVE INSIGHTS

Our report offerings include:

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

2. EXECUTIVE SUMMARY

3. MARKET DYNAMICS

4. KEY ANALYTICS

5. MARKET BY PROCEDURE

6. MARKET BY TYPE

7. MARKET BY END-USER

8. GEOGRAPHICAL ANALYSIS

9. COMPETITIVE LANDSCAPE

セルライト治療の世界市場規模予測（2023年～2032年）

Global Cellulite Treatment Market Forecast 2023-2032

目次

第1章 調査範囲と調査手法

第2章 エグゼクティブサマリー

第3章 市場力学

第4章 主要な分析

第5章 施術別の市場

第6章 タイプ別の市場

第7章 エンドユーザー別の市場

第8章 地域分析

第9章 競合情勢

LIST OF TABLES

LIST OF FIGURES

KEY FINDINGS

MARKET INSIGHTS

REGIONAL INSIGHTS

COMPETITIVE INSIGHTS

Our report offerings include:

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

2. EXECUTIVE SUMMARY

3. MARKET DYNAMICS

4. KEY ANALYTICS

5. MARKET BY PROCEDURE

6. MARKET BY TYPE

7. MARKET BY END-USER

8. GEOGRAPHICAL ANALYSIS

9. COMPETITIVE LANDSCAPE

第1章調査範囲と調査手法

第2章エグゼクティブサマリー

第3章市場力学

第4章主要な分析

第5章施術別の市場

第6章タイプ別の市場

第7章エンドユーザー別の市場

第8章地域分析

第9章競合情勢